Академический Документы
Профессиональный Документы
Культура Документы
2
0022-538X/00/$04.000
Copyright 2000, American Society for Microbiology. All Rights Reserved.
The initial steps of Venezuelan equine encephalitis virus (VEE) spread from inoculation in the skin to the
draining lymph node have been characterized. By using green fluorescent protein and immunocytochemistry,
dendritic cells in the draining lymph node were determined to be the primary target of VEE infection in the first
48 h following inoculation. VEE viral replicon particles, which can undergo only one round of infection,
Venezuelan equine encephalitis virus (VEE) is a positive- tral nervous system via the olfactory and trigeminal nerves,
sense, single-stranded RNA Alphavirus belonging to the family terminating in a fatal encephalitis 7 to 10 days p.i. (6).
Togaviridae. Epizootic strains of VEE cause significant disease Although lymphoid tissues represent a significant site of
in horses and humans, as evidenced by the 1995 to 1996 viral replication in the early stages of VEE pathogenesis (14,
epizootic in Venezuela and Columbia, during which an esti- 23, 34; Aronson et al., unpublished), specific cell targets for
mated 60,000 humans were infected following outbreaks in viral replication had not been identified. VEE expression vec-
surrounding horse populations (35). VEE is transmitted by tors (10, 27) encoding either the green fluorescent protein
mosquitoes, typically of the subgenus Culex, during the course (GFP) or influenza virus hemagglutinin (HA) were used in
of a blood meal. Infection by VEE causes a biphasic illness in conjunction with immunocytochemistry to demonstrate that
equines. The first phase is characterized by fever and viral VEE primarily targets dendritic cells (DC) in the lymph nodes.
replication in lymphoid tissues, with a high serum viremia (14, The use of VEE viral replicon particles (VRP), which can
19). In the second phase, in spite of immune system-mediated undergo only one round of infection, showed that VEE initially
clearance from peripheral tissues, virus invades the central infects Langerhans cells, the resident DC in the skin which
nervous system and leads to an often lethal encephalitis. In- migrate to the draining lymph node following activation. A
fection in humans results in much milder disease than that seen point mutation in the E2 glycoprotein gene of VEE that ren-
in equines and ranges from asymptomatic to flu-like symptoms ders the virus avirulent and compromises its ability to spread
and fever, with approximately 0.1 to 0.7% of cases resulting in beyond the draining lymph node (11, 18) blocked the appear-
encephalitis, most commonly in children and the elderly (18). ance of virally infected DC in the lymph node in vivo. A
Infection in rodent models closely parallels the encephalitic second-site suppressor mutation that restores viral spread to
disease seen in horses (14, 23). Following a subcutaneous (s.c.) lymphoid tissues and partially restores virulence (Aronson et
inoculation in the rear footpad of a mouse, replicating virus is al., unpublished; K. A. Bernard, personal communication) like-
first observed in the draining lymph node within 4 h postin- wise restored the ability of VEE to infect DC in vivo.
oculation (p.i.). This precedes replication at the site of inocu-
lation in the footpad by 6 to 8 h, suggesting that the primary
amplification occurs at the first lymphoid tissue encountered MATERIALS AND METHODS
and not at the site of inoculation (J. F. Aronson, N. L. Davis, Virus and mice. This study used viral particles derived directly from transfec-
F. B. Grieder, P. C. Charles, T. A. Knott, K. W. Brown, and tion of full-length or partial RNA transcripts of VEE cDNA clones into baby
R. E. Johnston, unpublished data). Virus titers of 106 to 107 hamster kidney (BHK) cells. These clones include pV3000, derived from the
Trinidad donkey strain of VEE (11, 12), and two mutated clones, pV3010 (11,
PFU/g of tissue are observed in the draining node as early as 18) and pV3533 (Aronson et al., unpublished). The infectious virus derived from
6 h p.i. (2). By 12 to 24 h p.i., high titers are observed in other these full-length clones are designated V3000, V3010, and V3533, respectively.
lymphoid tissues and serum, with lower titers being found in V3010 is isogenic with V3000 except at E2 76 (Glu 3 Lys). V3533 is a second-
several nonlymphoid tissues. By 48 to 72 h p.i., the titers begin site revertant of V3010 that was generated by the insertion of a suppressor
mutation at E2 116 (Lys 3 Glu) into the V3010 background. The E2 116
to decline, with necrosis in infected tissues. Complete clear- suppressor mutation was identified as a constituent mutation in a V3010 rever-
ance from the periphery occurs by 72 to 96 h p.i. However, at tant isolated from the serum of a V3010-infected mouse. The replication of
this point virus has already spread from the blood to the cen- V3533 in mice appears identical to that of the in vivo-isolated revertant.
Two types of VEE expression vectors derived from V3000 were used in these
studies (Fig. 1): a double-promoter vector (dpV3000) (10) and a replicon vector
(27). dpV3000 contains a second copy of the 26S subgenomic promoter inserted
* Corresponding author. Mailing address: Department of Microbi-
near the 3 end of the V3000 genome. dpV3000-GFP was generated by inserting
ology and Immunology, University of North Carolina at Chapel Hill a copy of a mutated form of GFP (mut2GFP) (7) downstream of the second 26S
School of Medicine, 804 Mary Ellen Jones Bldg., Campus Box 7290, promoter. This vector produces propagation-competent virus particles which
Chapel Hill, NC 27599-7290. Phone: (919) 966-4026. Fax: (919) 962- express GFP following infection and which can spread from cell to cell. In
8103. E-mail: gmacd@med.unc.edu. contrast, the replicon expression vectors have had the structural genes directly
914
VOL. 74, 2000 DENDRITIC CELL TARGETING BY VEE 915
replaced by a heterologous gene (10, 27) and were used to produce propagation- control primary Ab. To optimize DEC 205 reactivity, fixed frozen sections were
defective viral particles, which are limited to one round of infection. steamed for 25 min (or, in the case of tissues with GFP, warmed to 55C for 1 h)
Two replicon vectors, one expressing influenza virus HA (pHA-VRP) (27) and in 10 mM citrate (pH 6.0). Immunostaining patterns obtained by epitope re-
one expressing mut2GFP (pGFP-VRP), were used in these studies. pGFP-VRP trieval methods were confirmed by using fresh tissue sections fixed in acetone (10
was generated by cloning mut2GFP directly behind the 26S promoter in the place min). Sections were blocked in 10% normal serum (with 0.1% Tween 20 in PBS
of the structural genes. Infectious VRP were produced from these vectors by for DEC 205) for 1 h, washed in PBS, and incubated with the primary Ab
coelectroporation into BHK cells of RNA transcripts from the pGFP-VRP or overnight at 4C. Sections were incubated with a secondary Ab with the appro-
pHA-VRP, respectively, with two VEE helper vectors expressing VEE capsid priate fluorochrome (CY2, CY3, or Texas Red) either directly conjugated to the
and glycoprotein genes (Fig. 1c). Both helper vectors lack the viral packaging Ab or through an avidin-biotin bridge (Jackson ImmunoResearch Laboratories).
signal, which results in only the pGFP-VRP or pHA-VRP genome being pack- Isolation of VEE-infected cells. Mice were inoculated in all four footpads with
aged in VRP. GFP-VRP-3000 and HA-VRP-3000 were produced by electropo- 103 PFU of dpV3000-GFP, and 2 h later the popliteal, lateral iliac, accessory
ration with helpers expressing the wild-type (V3000) glycoproteins, whereas the axial, and proper axial lymph nodes were removed and minced into 1-mm2 pieces
mutated VRPs, GFP-VRP-3010 and GFP-VRP-3533, were packaged by using on ice in complete medium (RPMI-C: RPMI 1640, 10% fetal bovine serum FBS,
glycoprotein helpers containing the V3010 and V3533 mutations, respectively. 25 mM HEPES [pH 7.2], 100 U of penicillin per ml, 100 g of streptomycin per
While VRP are fully infectious, they can undergo only one round of infection and ml, 0.25 mg of amphotericin B per ml, 2 mM L-Gln, 50 M 2-mercaptoethanol,
were used to study the initial events of infection in vivo without the production 1 mM sodium pyruvate, 0.1 mM nonessential amino acids). Tissue fragments
and spread of viral progeny. The titer was determined on BHK cells as infectious were digested with collagenase (Sigma; type IA, 100 g/ml) and DNase (Sigma;
units (IU) by either immunofluorescence or immunocytochemistry. 30 U/ml) for 90 min at 37C. At 30-min intervals during the digestion, the
Female CD-1 or C57BL/6 mice, 7 to 8 weeks old (Charles River Laboratories, fragments were gently pipetted and the suspension cells were removed to ice,
Wilmington, Mass., and Jackson Laboratory, Bar Harbor, Maine, respectively) with fresh enzymes being added to the remaining fragments. The final cell
were inoculated s.c. in the footpad with 103 to 104 PFU of virus or IU of VRP. suspension was passed through a 70-m nylon cell sieve (Falcon) and washed
GFP detection and immunocytochemistry. At 7 to 48 h p.i., mice were per- twice. DC and macrophages were separated from lymphocytes by density cen-
fused with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS), and trifugation of a suspension of 0.5 106 to 1 106 cells/ml over a 14.5%
the draining popliteal lymph nodes were removed. For leg sections, whole legs Nycodenz (GIBCO BRL) cushion at 600 g for 20 min at 27C. Low-density
were decalcified in 8% EDTA4% PFA for 6 weeks before the sectioning was cells at the interphase (macrophages and DC) were separated from pelletted
performed. GFP-positive cells were visualized by fluorescence microscopy of lymphocytes, and both fractions were cultured in RPMI-C overnight (14 to 16 h)
fixed frozen sections by using a fluorescein isothiocyanate filter set. The following at 37C. DC were removed from the low-density cell culture by rigorous pipet-
antibodies (Abs) were used for immunostaining: rabbit anti-VEE (kind gift of J. ting, leaving the strongly adherent macrophages. The dendritic, macrophage, and
Smith, Ft. Detrick, Fredrick, Md.), anti-DEC 205 (NLDC145; American Type lymphocyte fractions were fixed in 4% PFA, and the number of GFP-positive
Culture Collection) and anti-CD11C (N418; American Type Culture Collection) cells in each fraction was counted by fluorescence microscopy. The purity of the
for DC, anti-CR-1 (PharMingen) and anti-FcIII/IIR (PharMingen) for follicu- DC and lymphocyte fractions was checked by immunofluorescence with DEC
lar DC; anti-CD11B (MAC-1) for macrophages, anti-MHC II IAdb (clone 205-, CD11B-, CD11C-, B220-, and CD5-specific Ab. Macrophages, T cells, and
25.9.175; both kindly provided by S. Virgin, Washington University, St. Louis, B cells represented 0.3, 1.0, and 5.8% of the DC fraction, respectively. Likewise,
Mo.), anti-CD45R (B220; PharMingen) for B cells, and anti-CD5 specific for T DC and macrophages represented 0.6 and 0.9%, respectively, of the lymphocyte
cells and Ly1 B cells (PharMingen). Rabbit anti-flu (H1N1; kindly provided by R. fraction.
Webster, St. Judes Children Hospital, Memphis) was used to detect influenza Kinetics of migration of VEE-infected cells. To determine the movement of
virus HA. Species-matched normal sera or isotype-matched monoclonal Ab VEE-infected cells from the site of inoculation to the draining lymph node, mice
(MAb) (PharMingen) was used in all immunostaining steps as the negative were inoculated s.c. with 103 IU of GFP-VRP-3000 in the rear footpad. At the
916 MACDONALD AND JOHNSTON J. VIROL.
FIG. 2. VEE infects DC in the draining lymph node. Sections of the draining popliteal lymph node 12 h following s.c. inoculation in the rear footpad either with
103 PFU of dpV3000-GFP (a to c), showing the distribution and morphology of GFP-positive cells in the cortex of the draining popliteal lymph node (a and b)
(magnification, 100 and 400, respectively) and around B-cell follicles immunostained with the B-cell-specific Mab, B220 (c) (magnification, 200), or with 103 PFU
of V3000 (d to f), showing double immunostaining with VEE-specific Ab (CY2; green) and the DC-specific Ab, DEC 205, (Texas Red; red) visualized by using either
Texas Red filters (d), fluorescein isothiocyanate filters (e), or triple-pass filters allowing simultaneous visualization of CY2 and Texas Red (f; magnification, 400).
times specified, two mice were sacrificed by cervical dislocation, the femoral RESULTS
arteries were severed, and the footpad and draining lymph nodes were surgically
removed. Tissue explants were cultured at 37C in RPMI-C for a total of 12 h (in
vivo plus ex vivo) prior to fixation in 4% PFA. Tissues were serially sectioned, VEE infects DC in the draining lymph node. The dpV3000-
and the total number of GFP-positive cells in each tissue was determined by GFP vector encodes all virus genes in addition to GFP and
fluorescence microscopy. allows viral spread from cell to cell over time to be studied by
VOL. 74, 2000 DENDRITIC CELL TARGETING BY VEE 917
TABLE 1. VEE-infected cells cofractionate with DC tive cells were observed in the macrophage population in one
from the lymph node experiment, and the four positive cells observed in the second
No. of GFP-positive Total no. of GFP-positive experiment were loosely adherent, most probably representing
Expt Cell fraction DC that had not been removed from the dish. These results are
cells per 107 cells cells countedc
consistent with the immunocytochemical observations indicat-
1 DC 660b 178 ing that DC represent a major target for infection by VEE.
Lymphocytes 0.4a 1
Macrophages 0b 0
Langerhans cells are the first cells infected by VEE follow-
ing s.c. inoculation. VRP are propagation-defective viral par-
2 DC 556b 139 ticles and can undergo only one round of infection. Therefore,
Lymphocytes 4a 16 VRP-infected cells necessarily represent the population of
Macrophages 4b 4 cells first infected by the virus. VRP expressing either GFP or
a HA (Fig. 1c) were used to identify the initial set of cells which
Number of GFP-positive cells counted per 107 lymphocytes plated.
b
Number of GFP-positive cells counted per 107 low-density cells plated. are infected by the virus following an s.c. injection in the
c
Total number of cells counted per fraction. footpad. Mice were inoculated with a low dose (103 IU) of
GFP-VRP-3000 s.c. in the rear footpad, and serial sections of
either the whole leg or the draining popliteal lymph node were
examined. Examination of whole-leg serial sections at 12 and
FIG. 3. Langerhans cells are the first cells infected following inoculation. (a and b) A leg section showing the draining popliteal lymph node 12 h following s.c.
inoculation in the rear footpad with 103 IU of GFP-VRP-V3000 (magnification, 100 and 400, respectively). (c to f) Draining lymph node sections from mice 8 h
after being infected with 103 IU of HA-VRP-3000 were doubly immunostained with Ab specific for either influenza virus (c and e), DC (d; DEC 205), or MHC class
II (f), and 0.5-m-thick sections were analyzed by confocal microscopy (magnification, 600).
A single mutation in the VEE E2 glycoprotein gene prevents and the ability of the virus to spread beyond the draining lymph
infection of DC in the lymph node. A single mutation intro- node (11, 18). VRP were packaged in V3010 structural pro-
duced into the E2 glycoprotein gene of V3000 to generate the teins to determine the effect of this mutation on the targeting
V3010 mutant severely affects both the virulence of the virus of Langerhans cells. Examination of serial sections through
VOL. 74, 2000 DENDRITIC CELL TARGETING BY VEE 919
entire draining lymph nodes demonstrated that this mutation the first cells infected via this route of inoculation. Identical
effectively prevents the appearance of GFP-positive Langer- results were found when mice were inoculated with propaga-
hans cells in the draining lymph node. Occasionally, small, tion-competent virus expressing GFP and were sacrificed at the
irregular GFP-positive cells were observed deep in the medulla earliest time when GFP could be detected. GFP expression in
(Fig. 5a). These cells also were found at low frequencies in these cells unambiguously confirms a productive viral infection
lymph nodes from mice inoculated with V3000. No GFP-pos- as opposed to antigen trapped on cell surfaces. While it is
itive cells were observed in other tissues of the lower leg, possible that DC have taken up GFP via phagocytosis of other
including the site of inoculation in the footpad. infected cell types, both the uniform distribution of GFP in the
A second-site suppressor mutation restores the ability of cytoplasm and the limited phagocytic characteristics of lymph
VEE to infect DC in vivo. The introduction of a second-site node DC argue against this.
suppressor mutation into the V3010 E2 glycoprotein gene At later time points, virus spreads to DC that are strongly
(clone V3533), originally isolated as an in vivo reversion, re- positive for DEC 205 in the paracortex of the draining lymph
stores the ability of the virus to spread and replicate in lym- node. DEC 205 is typically associated with interdigitating DC,
phoid tissues beyond the draining lymph node and partially a subset of DC which is associated with the T-cell-rich regions
restores viral virulence (Aronson et al., unpublished; Bernard, of the deep cortex of lymph nodes (29). The presence of virally
personal communication). We tested the effect of this second infected cells that are DEC 205 positive in the subcortical
mutation on cell targeting in vivo by inoculating mice with region between B-cell follicles may be a direct consequence of
VRP packaged in V3533 glycoproteins. At a dose of 103 IU, VEE infection or may represent a distinct subset of DC which
GFP-VRP-V3533 infected cells with a DC-like morphology share this marker with interdigitating DC. The cofractionation
located within B-cell follicles (Fig. 5b). These cells were posi- of GFP-positive cells in the DC fraction of lymph nodes further
tive for FcIII/IIR (Fig. 5d) and CR-1 (Fig. 5f), consistent with indicates that DC, as opposed to lymphocytes and macro-
markers of follicular DC (22), but were negative for DEC 205, phages, represent the major target of infection in these tissues.
CD11B, CD11C, and lymphocyte markers. At a higher dose of The targeting of VEE to both Langerhans cells and DC is
104 IU, GFP-VRP-3533 infected cells that were positive for consistent with data indicating that Langerhans cells differen-
DEC 205, CD11B, and CD11C (data not shown), similar to tiate into DC when they migrate from the skin to the lymph
VRP-3000 at 104 IU. These results demonstrate that at lower node. Langerhans cells are the resident DC of the skin, where
doses, the V3533 revertant has acquired the ability to infect a they act as scavengers or sentinels for foreign antigens (1, 31,
new subset of DC, but at higher doses, it infects a cell popu- 33). These cells are nonmobile and express low levels of MHC
lation comparable to that infected by the wild-type virus. class II and DEC 205. Upon activation by antigen uptake or by
cytokines such as tumor necrosis factor alpha, they differenti-
DISCUSSION ate into mobile veiled cells and migrate through the lymph to
the draining lymph node. In the lymph node, they further
The initial events in the course of viral infection often de- differentiate into potent antigen-presenting cells which express
termine the outcome and severity of viral disease. We have high levels of MHC class II and DEC 205 (1, 8, 9, 29, 31, 33).
characterized the initial steps of VEE spread and pathogenesis Langerhans cells infected with VRP appeared to have retained
from the s.c. site of inoculation to the draining lymph node. the characteristics of skin Langerhans cells in the lymph node
Through the use of propagation-defective VEE vectors, we without further maturation, even over the 5-day period during
have demonstrated that Langerhans cells, DC of the skin, were which they can be detected in the node. Alphaviruses inhibit
920 MACDONALD AND JOHNSTON J. VIROL.
FIG. 5. A single mutation in the VEE E2 glycoprotein gene prevents infection in vivo of DC, while a second-site suppressor mutation restores the ability of VEE
to infect DC. Sections of the draining lymph node 12 h following s.c. inoculation in the rear footpad with 103 IU of either GFP-VRP-V3010 (magnification, 600) (a),
GFP-VRP-V3533 (magnification, 400) (b), or HA-VRP-V3533 (c to f). HA-GFP-V3533 sections were doubly immunostained with Ab specific for influenza virus and
FcIII/IIR and analyzed by confocal microscopy (magnification, 600) (c and d) or for influenza virus and CR-1 (e and f) and analyzed by fluorescence microscopy
(magnification, 600) (e and f).
host protein synthesis in cultured cells 4 to 6 h after infection Although a number of viruses are able to infect DC in vitro,
(30). It is possible that VRP infection of Langerhans cells a limited number of organisms have actually been demon-
perturbed cellular protein synthesis to the extent that the mat- strated to infect DC in vivo. These include human immunode-
uration of these cells in the lymph node was halted at an ficiency virus (13, 28), lymphocytic choriomeningitis virus
intermediate differentiation state. If this is the case, VEE may (LCMV) (3), African swine fever virus (16), adenovirus (15),
provide a valuable tool in studying Langerhans cell differenti- murine retrovirus SL3-3 (32), and the protozoan parasite
ation in vivo and in vitro. Leishmania major (24). In the case of adenovirus, human im-
VOL. 74, 2000 DENDRITIC CELL TARGETING BY VEE 921
munodeficiency virus, and L. major, cell types other than DC capable of only a single cycle of replication, thus unequivocally
represent additional significant targets of infection. In LCMV, identifying the earliest pathogenic events following inocula-
however, a mutation introduced into the Armstrong strain tion.
(clone 13) shifts cell tropism from macrophages primarily to
DC in the spleen.
Pathogen infection of DC, as described in several systems, ACKNOWLEDGMENTS
can promote potent antipathogen immunity due to efficient
antigen presentation and/or immunosuppression due to im- This research was supported by grants NS26681 and A122186 from
pairment or depletion of infected DC (2). Persistent L. major the Public Health Service and by the U.S. Army Research and Devel-
infection of DC is correlated with healing of lesions, lifelong opment Command under contract DAMD17-94-J-4430. G.H.M. grate-
fully acknowledges support from National Research Service Award
immunity, and resistance to reinfection (24), whereas the shift NIH F32-AI09778.
in cell tropism in the LCMV clone 13 results in a broad im- We acknowledge the excellent technical support of Cherice Connor,
munosuppression due to the depletion of infected DC (3). Jacque Bailey, and Dwayne Muhammed.
Measles virus infection of DC in vitro results in a loss of
antigen-presenting capacity and has been proposed as a major
cause of the transient immunosuppression seen following mea- REFERENCES
sles virus infections in vivo (2, 20). As with L. major, VEE 1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of
20. Grosjean, I., C. Caux, C. Bella, I. Berger, F. Wild, J. Banchereau, and D. tion against heterologous pathogens in vivo. Virology 239:389401.
Kaiserlian. 1997. Measles virus infects human dendritic cells and blocks their 28. Rappersberger, K., S. Gartner, P. Schenk, G. Stingl, V. Groh, E. Tschachler,
allostimulatory properties for CD4 T cells. J. Exp. Med. 186:801812. D. L. Mann, K. Wolff, K. Konrad, and M. Popovic. 1988. Langerhans cells
21. Hevey, M., D. Negley, P. Pushko, J. Smith, and A. Schmaljohn. 1998. Mar- are an actual site of HIV-1 replication. Intervirology 29:185194.
burg virus vaccines based upon alphavirus replicons protect guinea pigs and 29. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell
nonhuman primates. Virology 251:2837. areas of lymphoid organs. Immunol. Rev. 156:2537.
22. Imai, Y., and M. Yamakawa. 1996. Morphology, function and pathology of 30. Strauss, J. H., and E. G. Strauss. 1994. The alphaviruses: gene expression,
follicular dendritic cells. Pathol. Int. 46:807833. replication, and evolution. Microbiol. Rev. 58:491562.
23. Jackson, A. C., S. K. SenGupta, and J. F. Smith. 1991. Pathogenesis of 31. Udey, M. C. 1997. Cadherins and Langerhans cell immunobiology. Clini.
Venezuelan equine encephalitis virus infection in mice and hamsters. Vet.
Exp. Immunol. 107(Suppl. 1):68.
Pathol. 28:410418.
32. Uittenbogaart, C. H., W. Law, P. J. Leenen, G. Bristol, W. van Ewijk, and
24. Moll, H., S. Flohe, and M. Rollinghoff. 1995. Dendritic cells in Leishmania
E. F. Hays. 1998. Thymic dendritic cells are primary targets for the oncogenic
majorimmune mice harbor persistent parasites and mediate an antigen-
specific T cell immune response. Eur. J. Immunol. 25:693699. virus SL3-3. J. Virol. 72:1011810125.
25. Moll, H., H. Fuchs, C. Blank, and M. Rollinghoff. 1993. Langerhans cells 33. van Wilsem, E. J., J. Breve, M. Kleijmeer, and G. Kraal. 1994. Antigen-
transport Leishmania major from the infected skin to the draining lymph bearing Langerhans cells in skin draining lymph nodes: phenotype and ki-
node for presentation to antigen-specific T cells. Eur. J. Immunol. 23:1595 netics of migration. J. Investig. Dermatol. 103:217220.
1601. 34. Walker, D. H., A. Harrison, K. Murphy, M. Flemister, and F. A. Murphy.
26. Olmsted, R. A., W. J. Meyer, and R. E. Johnston. 1986. Characterization of 1976. Lymphoreticular and myeloid pathogenesis of Venezuelan equine en-
Sindbis virus epitopes important for penetration in cell culture and patho- cephalitis in hamsters. Am. J. Pathol. 84:351370.
genesis in animals. Virology 148:245254. 35. Weaver, S. C., R. Salas, R. Rico-Hesse, G. V. Ludwig, M. S. Oberste, J.